NKF invests in technology to improve home dialysis
Click Here to Manage Email Alerts
The National Kidney Foundation Innovation Fund announced it invested in Revalo to continue developing PeritoneX technology, according to a press release.
PeritoneX is designed to internally disinfect dialysis tubes in the peritoneal dialysis system as an in-line connection device. The device is compatible with existing PD systems and is intended to reduce peritonitis.
“Fear of infection during PD has been the largest barrier to expanded utilization of PD,” Kevin Longino, CEO of NKF and a kidney transplant recipient, said in the release. “We believe this technology will help address those fears and improve health equity. PeritoneX aims to expand access to home dialysis for more patients, especially those with limited access to transportation, or those patients in rural communities who travel long distances to dialysis centers.”
In a laboratory setting, PeritoneX managed a greater than five-log reduction against various bacteria with potential to cause peritonitis. Moreover, patients may be at less of a risk for secondary contamination while using PeritoneX given they can continue to receive treatment with the connector in place.
“We are thrilled to receive support from the NKF. From our inception, we have strived to develop a patient- and user-centric device that makes peritoneal dialysis safer. We want to reduce the barriers to PD and make clinicians, patients, and care partners feel safer and more confident in their care. We are excited to continue this work and believe that the NKF will be an ideal partner as we grow,” Sarah Lee, CEO and co-founder of Relavo, said in the release.
Read more about
Click Here to Manage Email Alerts